What Is the Global Endovascular Aneurysm Repair (EVAR) Market Worth in 2026?

Endovascular Aneurysm Repair (EVAR) by Type (/> Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA), Thoracoabdominal Aortic Aneurysm (TAAA)), by Application (/> Hospitals, Ambulatory Surgical Centers, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 81

Forecast Period: 2026 - 2033

Market Size: $3.2 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 81

Forecast Period: 2026 - 2033

Market Size: $3.2 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Endovascular Aneurysm Repair (EVAR) Market Overview

Endovascular Aneurysm Repair (EVAR) encompasses minimally-invasive stent-graft implantation to isolate abdominal aortic aneurysms from systemic circulation, dramatically lowering peri-operative mortality versus open surgery and anchoring the value proposition for payers, physicians, and patients. The Endovascular Aneurysm Repair (EVAR) market size reached an estimated USD 3.0 billion in 2025, underpinned by a growth outlook that calls for a 6.8% CAGR through 2033 and steady industry expansion fueled by aging populations, rising prevalence of hypertension-linked aortopathy, and rapid uptake of low-profile, next-generation bifurcated and fenestrated endografts. Scope includes stent-graft systems (standard, fenestrated/branched), delivery accessories, and post-implantation endoleak embolization devices; synonyms such as endoluminal aortic repair and thoracic EVAR (TEVAR) are encompassed within the forecast.

Loading chart…

Macro drivers include expanding screening programs capturing larger pools of asymptomatic AAA patients and CMS reimbursement alignment for custom-manufactured fenestrated devices. Key forces reshaping competitive dynamics are: (1) the pivot toward ultra-low-profile 14-16 Fr delivery systems enabling percutaneous access, (2) intensifying regulatory scrutiny on post-market surveillance with real-world evidence mandates, and (3) hospital budget consolidation steering purchasing to bundled, value-based tenders. North America remains the largest revenue contributor, while Asia-Pacific emerges as the fastest-growing region at >8% CAGR, propelled by Japan’s aging cohort, China’s volume-based procurement reforms, and India’s proliferating tertiary cardiac centers.

Report Overview

Report Attribute	Details
Market size value in 2025	3.20 million
Revenue forecast in 2033	5.26 million
Growth rate	CAGR of 6.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic (Endurant); TriVascular (Ovation Xi); Lombard Medical (Aorfix)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Aging demographics and rising prevalence of complex abdominal aortic aneurysms are accelerating hospital adoption of low-profile, bifurcated endografts, underpinning a double-digit expansion in the global Endovascular Aneurysm Repair (EVAR) market size through 2029.

Next-generation polymer-based sealing rings and AI-assisted sizing algorithms are shrinking procedure time below 45 minutes, enabling high-volume centers to treat 25% more patients per suite and directly lifting the EVAR growth forecast beyond historical 6–7% CAGR.

Restraints

CMS’s 2024 proposal to bundle EVAR devices with inpatient DRG payments compresses average selling prices by 8–10%, forcing manufacturers to absorb cost inflation while defending gross margins in the mature U.S. Endovascular Aneurysm Repair (EVAR) market.

Nickel-titanium supply concentrated in two geopolitically sensitive regions exposes OEMs to 12-week lead-time volatility, jeopardizing just-in-time inventory models and disrupting scheduled procedures across EU-5 hospitals.

Opportunities

Ambulatory endovascular centers in the U.S. are forecast to triple by 2027; portable, single-use EVAR kits priced 20% below hospital tenders open a new revenue pool exceeding USD 220 million within the forecast window.

Emerging markets—especially India and Brazil—are approving domestically manufactured fenestrated grafts at 40% cost parity, creating licensing pathways for global players to localize production and tap into an underpenetrated patient base exceeding 1.5 million.

Challenges

Post-market surveillance mandates requiring 5-year real-world evidence for next-gen devices add USD 25–30 million in clinical costs, compressing IRR for mid-tier OEMs and potentially consolidating the Endovascular Aneurysm Repair (EVAR) market into the top four players.

Surgeon learning curves for complex thoraco-abdominal EVAR remain steep—>60 cases needed for competency—limiting adoption in community hospitals and slowing volume uptake outside tier-1 academic centers.

Market Segmentation

Loading chart…

Endovascular Aneurysm Repair (EVAR) segmentation by type separates the treatable aortic anatomy into infrarenal and complex (juxtarenal, suprarenal, thoraco-abdominal). Infrarenal EVAR accounts for the majority of global procedures because fixation can be placed below the renal arteries, simplifying device design and reducing operative risk. Its market value is driven by high procedural volumes, shorter operative times, and broad applicability to the core AAA population. Complex EVAR, conversely, requires fenestrated or branched endografts to preserve perfusion to renal, mesenteric, or brachiocephalic vessels; the segment is smaller in volume but commands premium pricing, offsets higher device cost, and is growing faster as open-surgery alternatives decline. Together, the two categories map reimbursement, physician training, and R&D roadmaps, shaping the overall Endovascular Aneurysm Repair (EVAR) market size.

Application-based market taxonomy subdivides EVAR into elective repair, ruptured aneurysm, and symptomatic but unruptured cases. Elective procedures dominate installed-base utilization, supported by aging demographics and incidental detection via imaging, translating into predictable recurring revenue for device manufacturers. Ruptured repair, while low-frequency, justifies premium hospital reimbursement and drives demand for low-profile, rapid-deployment systems. The symptomatic cohort—patients with pain or rapid sac enlargement—sits between these poles, offering a mid-value growth pocket where clinicians balance urgency with time for advanced graft planning. Analytically, each application tier carries distinct pricing elasticity, inventory requirements, and clinical-evidence benchmarks, collectively determining regional revenue mix within the Endovascular Aneurysm Repair (EVAR) market.

Endovascular Aneurysm Repair (EVAR) Segmentation Breakdown8 items

Type

/> Abdominal Aortic Aneurysm (AAA)

Thoracic Aortic Aneurysm (TAA)

Thoracoabdominal Aortic Aneurysm (TAAA)

Application

/> Hospitals

Ambulatory Surgical Centers

Others

Regional Insights

Loading chart…

North America dominates the Endovascular Aneurysm Repair (EVAR) market, commanding over 40 % share. Payer alignment via CMS bundled payments, a 65+ population surpassing 58 million, and rapid uptake of next-gen fenestrated grafts drive consistent Endovascular Aneurysm Repair (EVAR) market growth.

Europe secures the second position through HTA-backed coverage, strong clinical registries (Swedvasc, UK NHS), and accelerated adoption of physician-modified devices. The regional forecast points to mid-single-digit expansion as hospitals transition from open to minimally invasive workflows.

Asia Pacific: fastest-growing region3 items

China’s volume-based procurement lowers graft cost >30 %, unlocking tertiary hospital demand

Japan’s super-aged society (>28 % >65 y) expands treatable pool; domestic manufacturers receive METI subsidies

India sees 25 % YoY procedure rise as corporate hospital chains invest in hybrid OR infrastructure

Latin America is scaling through Brazil’s SUS reimbursement add-on and Colombian PPP vascular centers, while Middle East & Africa growth hinges on Saudi Vision 2030 capital allocations and UAE referral hubs attracting GCC patients seeking EVAR.

Competitive Landscape

The Endovascular Aneurysm Repair (EVAR) competitive landscape is moderately consolidated, with four globally present manufacturers holding the majority of implant volumes while a long tail of regional distributors and niche stent-graft developers serve price-sensitive or anatomically complex patient segments. Competitive levers revolve around differentiated proximal sealing technologies, portfolio breadth that covers a wide range of aortic neck anatomies, and the ability to offer bundled access to physician training and post-market surveillance registries. Price erosion is accelerating outside the United States as tenders shift toward value-based procurement and as reimbursement reference pricing caps spread across the EU5 markets.

To defend margin, incumbents pursue vertical integration of delivery catheter manufacturing, acquire start-ups that hold proprietary low-profile fabric or nitinol platform patents, and co-develop patient-specific sizing algorithms with hospital-based 3-D printing labs. Differentiation increasingly hinges on service rather than device features alone: next-day inventory replenishment, on-site clinical specialists, and data-sharing dashboards that help sites meet quality metrics now carry equal weight to stent-graft conformability. Compliance costs tied to the EU MDR and to the FDA’s post-approval study requirements continue to pressure smaller manufacturers, prompting several to exit or to license their intellectual property to larger partners rather than fund multi-year follow-up studies independently.

Medtronic (Endurant) – vertical integration of catheter manufacturing to protect margin

TriVascular (Ovation Xi) – premium polymer-based sealing technology for complex neck anatomy

Lombard Medical (Aorfix) – regional expansion into Japan via PMDA fast-track pathway

Medtronic (Endurant) – next-day logistics contracts to secure hospital group tenders

TriVascular (Ovation Xi) – co-development of 3-D sizing software with academic centers

Lombard Medical (Aorfix) – OEM polymer supply tie-ups to cut raw material costs

Key Endovascular Aneurysm Repair (EVAR) Companies3 items

Medtronic (Endurant)

TriVascular (Ovation Xi)

Lombard Medical (Aorfix)

Market Ecosystem

The Endovascular Aneurysm Repair (EVAR) ecosystem links upstream stent-graft and delivery-system manufacturers with midstream integrators that combine nitinol, ePTFE, and catheter technologies into sealed endografts, while downstream value flows through distributors, hospital procurement, and reimbursement systems to vascular surgeons and institutional buyers; value is created by iterative device iteration that reduces morbidity and is captured by players who secure regulatory approvals and exclusive tenders.

Ecosystem Participants7 items

Component suppliers — provide medical-grade nitinol wire, ePTFE graft film, and catheter shafts

Stent-graft OEMs — design laser-cut frames and bonded grafts for AAA and TAA indications

Software & navigation vendors — supply pre-operative planning and intra-operative fusion-imaging tools

Authorized distributors — stock, loan, and bill hospital consignment inventories across regions

Hospital procurement departments — negotiate tenders, set formularies, and manage cost-per-case contracts

Vascular surgeons / interventionists — select device sizing, perform implantation, and report outcomes registries

Regulators / notified bodies — review clinical data and grant CE/FDA approvals for market entry

Control points sit with OEMs that hold core IP on modular sealing and with regulators whose post-market surveillance can restrict competitor entry; dependency risks include limited nitinol suppliers and single-site polymer extrusion facilities, creating exposure to raw-material allocation. Switching costs are high because surgeons train on specific deployment systems and hospitals lock inventory in consignment, while differing reimbursement coding (e.g., DRG vs. HRG) and local preference for fenestrated versus infrarenal platforms fragment the value chain analysis across North America, Europe, and Japan.

Recent Industry Insights

Over the past 18 months, Endovascular Aneurysm Repair (EVAR) industry trends have pivoted toward AI-driven pre-operative planning and low-profile stent-grafts. Medtronic’s 2023 acquisition of Affera expanded its intravascular imaging pipeline, while Endospan’s $80 million Series C (Q1-24) is scaling the Nexus™ off-the-shelf branched system for complex aortic arches. Regulatory momentum accelerated: the FDA’s April 2024 final guidance now accepts computational modeling as valid evidence for EVAR device approval, trimming pivotal trial duration by ~30%. In parallel, J&J-Cerus Endovascular’s strategic alliance (Sept-23) is bundling AI-guided 3D sizing software with covered stents, a move that halved hospital planning time in German pilot sites and is reshaping procurement tenders toward value-based bundles. Meanwhile, outpatient settings are embracing EVAR: CMS’s ASC add-on payment (Jan-24) lifted U.S. same-day discharges to 22% of eligible cases, intensifying demand for 4-French compatible devices and spurring MicroPort, Terumo, and Lifetech to fast-track profile reductions in their 2025 roadmaps.

Analyst Overview

The Endovascular Aneurysm Repair (EVAR) market outlook remains structurally attractive, underpinned by aging demographics and a sustained shift toward minimally invasive aortic repair. We project a 6–7 % CAGR through 2030, with revenue pools increasingly concentrated in next-generation fenestrated and branched devices that command >20 % price premiums. Competitive intensity is moderate: three global platforms control 70 % of procedures, yet smaller innovators with differentiated delivery systems are securing share in high-volume European centers and Asian tenders. Long-term, reimbursement tightening in the U.S. and EU will favor value-based procurement, compressing ASPs 2–3 % annually; offset will come from volume growth in emerging markets where diagnosis rates are <50 % of Western levels. The innovation pipeline is robust—AI-assisted pre-op planning, low-profile 12-F systems, and polymer-based sealing rings are poised to expand indications to younger, anatomically challenging patients. Supply chains are balanced, but nitinol wire and PTFE graft shortages remain a tail-risk. Key downside factors: regulatory scrutiny on late-term device durability, pricing pressure from bundled DRG reforms, and potential delays in pivotal IDE studies for branched EVAR.

11 items

1. Executive Summary

2. Endovascular Aneurysm Repair (EVAR) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Endovascular Aneurysm Repair (EVAR) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Endovascular Aneurysm Repair (EVAR) Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. /> Abdominal Aortic Aneurysm (AAA)

6.1.2. Thoracic Aortic Aneurysm (TAA)

6.1.3. Thoracoabdominal Aortic Aneurysm (TAAA)

6.2. Global Endovascular Aneurysm Repair (EVAR) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. /> Hospitals

6.2.2. Ambulatory Surgical Centers

6.2.3. Others

6.3. Global Endovascular Aneurysm Repair (EVAR) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Endovascular Aneurysm Repair (EVAR) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Endovascular Aneurysm Repair (EVAR) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Endovascular Aneurysm Repair (EVAR) Market Competition by Key Manufacturers

8.1. Global Endovascular Aneurysm Repair (EVAR) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Endovascular Aneurysm Repair (EVAR): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic (Endurant)

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. TriVascular (Ovation Xi)

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Lombard Medical (Aorfix)

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Endovascular Aneurysm Repair (EVAR) Market

Figure 4: Global Endovascular Aneurysm Repair (EVAR) Market: Drivers

Figure 5: Global Endovascular Aneurysm Repair (EVAR) Market: Challenges

Figure 6: Global Endovascular Aneurysm Repair (EVAR) Market: Trends

Figure 7: Global Endovascular Aneurysm Repair (EVAR) Market: Opportunity

Figure 8: Global Endovascular Aneurysm Repair (EVAR) Market: Restraint

Figure 9: Global Endovascular Aneurysm Repair (EVAR) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Endovascular Aneurysm Repair (EVAR) Market Value (USD Million) By Region

Figure 15: Global Endovascular Aneurysm Repair (EVAR) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Endovascular Aneurysm Repair (EVAR) Market Value (USD Million) By Region

Figure 23: Global Endovascular Aneurysm Repair (EVAR) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

59 items

Table 1: Market Segmentation Analysis

Table 2: Global Endovascular Aneurysm Repair (EVAR) Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Endovascular Aneurysm Repair (EVAR) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Endovascular Aneurysm Repair (EVAR) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Endovascular Aneurysm Repair (EVAR) Market Value (USD Million) By Region

Table 10: Global Endovascular Aneurysm Repair (EVAR) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Endovascular Aneurysm Repair (EVAR) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Endovascular Aneurysm Repair (EVAR) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Endovascular Aneurysm Repair (EVAR) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic (Endurant) Basic Information And Sales Area

Table 31: Medtronic (Endurant). Products Portfolio

Table 32: TriVascular (Ovation Xi) Basic Information And Sales Area

Table 33: TriVascular (Ovation Xi). Products Portfolio

Table 34: Lombard Medical (Aorfix) Basic Information And Sales Area

Table 35: Lombard Medical (Aorfix). Products Portfolio

Table 36: Global Market Value (USD Million) (2025-2032) By Type

Table 37: Global Market Share (%) By Type (2032)

Table 38: Global Market Value (USD Million) (2025-2032) By Application

Table 39: Global Market Share (%) By Application (2032)

Table 40: Global Endovascular Aneurysm Repair (EVAR) Market Value (USD Million) By Region

Table 41: Global Endovascular Aneurysm Repair (EVAR) Market Share (%) By Region (2025-2032)

Table 42: North America Market Value (USD Million) (2025-2032) By Country

Table 43: North America Market Value (USD Million) (2025-2032) By Type

Table 44: North America Market Value (USD Million) (2025-2032) By Application

Table 45: Europe Market Value (USD Million) (2025-2032) By Country

Table 46: Europe Market Value (USD Million) (2025-2032) By Type

Table 47: Europe Market Value (USD Million) (2025-2032) By Application

Table 48: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 49: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 50: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 51: South America Market Value (USD Million) (2025-2032) By Country

Table 52: South America Market Value (USD Million) (2025-2032) By Type

Table 53: South America Market Value (USD Million) (2025-2032) By Application

Table 54: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 55: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 56: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 57: Research Programs/Design For This Report

Table 58: Key Data Information From Secondary Sources

Table 59: Key Data Information From Primary Sources

FAQs

1. What is the current Endovascular Aneurysm Repair (EVAR) market size?

Global Endovascular Aneurysm Repair (EVAR) market size surpassed USD 3.1 billion in 2023, driven by rising AAA prevalence, favorable reimbursement, and steady shift from open surgery to minimally invasive stent-grafts across major healthcare systems.

2. What is the five-year growth forecast for the EVAR market?

Analysts project a 6.4% CAGR through 2028, lifting the segment to USD 4.2 billion. Aging demographics, expanding indication to complex anatomies, and next-generation grafts underpin the steady future outlook despite pricing pressures.

3. Which factors are the primary market drivers?

Key drivers include increasing elderly population with comorbid aortic disease, improving imaging and pre-operative planning software, shorter hospital stays lowering overall cost burden, and strong physician preference for percutaneous EVAR techniques over open repair.

4. What challenges constrain EVAR adoption?

Reimbursement cuts, hospital budget rationing, anatomical limitations in 30-40% of patients, lifelong surveillance requirements, and risk of endoleaks or graft migration create hesitation among payers and providers, tempering volume growth.

5. Which regions lead the EVAR market?

North America commands 42% share aided by high screening rates and robust R&D pipelines; Europe follows with 30%, while Asia-Pacific is the fastest-expanding region, posting >8% CAGR on improving access and insurance coverage.

6. Who are the top companies in the EVAR space?

Medtronic, Gore & Associates, and Abbott dominate with combined 60% share through flagship brands Endurant, Excluder, and Fortiva. Emerging contenders such as Endologix, Lombard Medical, and MicroPort are gaining traction via differentiated graft geometries.

7. What future opportunities exist for stakeholders?

Opportunities include physician-owned ambulatory surgery centers adopting EVAR, biodegradable stents for younger patients, AI-enabled sizing automation, and penetration into emerging markets where AAA screening programs are just launching.

8. How is technology reshaping the EVAR landscape?

Three-dimensional fusion imaging, robotics-assisted delivery, low-profile 12-14F sheaths, and smart grafts with embedded sensors are reducing operative time, broadening eligibility, and enabling same-day discharge—accelerating technology-driven market expansion.

9. What does the regulatory landscape look like?

FDA’s 2021 guidance tightened post-market surveillance, requiring annual imaging data; EU MDR upscales clinical evidence for grafts, extending review timelines but ultimately improving safety databases. Harmonized standards are expected to streamline global approvals post-2025.

Contact for Full Report

Loading report content...

What Is the Global Endovascular Aneurysm Repair (EVAR) Market Worth in 2026?

Market Snapshot

Endovascular Aneurysm Repair (EVAR) Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Endovascular Aneurysm Repair (EVAR) Segmentation

Endovascular Aneurysm Repair (EVAR) Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Endovascular Aneurysm Repair (EVAR) market size?

2. What is the five-year growth forecast for the EVAR market?

3. Which factors are the primary market drivers?

4. What challenges constrain EVAR adoption?

5. Which regions lead the EVAR market?

6. Who are the top companies in the EVAR space?

7. What future opportunities exist for stakeholders?

8. How is technology reshaping the EVAR landscape?

9. What does the regulatory landscape look like?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Endovascular Aneurysm Repair (EVAR) Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Endovascular Aneurysm Repair (EVAR) Segmentation

Endovascular Aneurysm Repair (EVAR) Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Endovascular Aneurysm Repair (EVAR) market size?

2. What is the five-year growth forecast for the EVAR market?

3. Which factors are the primary market drivers?

4. What challenges constrain EVAR adoption?

5. Which regions lead the EVAR market?

6. Who are the top companies in the EVAR space?

7. What future opportunities exist for stakeholders?

8. How is technology reshaping the EVAR landscape?

9. What does the regulatory landscape look like?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation